Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-EN | Version v5-FR | |
---|---|---|
Language | English | French |
Date Updated | 2017-04-24 | 2017-03-16 |
Drug Identification Number | 02237815 | 02237815 |
Brand name | ERWINASE | ERWINASE |
Common or Proper name | Erwinia L-asparaginase | Erwinia L-asparaginase |
Company Name | JAZZ PHARMACEUTICALS FRANCE SAS | JAZZ PHARMACEUTICALS FRANCE SAS |
Ingredients | ASPARAGINASE | ASPARAGINASE |
Strength(s) | 10000UNIT | 10000UNIT |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 3 mL vials | 3 mL vials |
ATC code | L01XX | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2017-03-14 | 2017-03-14 |
Actual start date | ||
Estimated end date | 2017-06-30 | 2017-04-30 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Reason for ongoing shortage in Canada (less than 3-months supply) due to global capacity constraints in manufacturing leading to just-in time supply with intermittent shortages. Additionally demand has increased from average of 51 packs per month to 105 packs per month. | Reason for ongoing shortage in Canada (less than 3-months supply) due to global capacity constraints in manufacturing leading to just-in time supply with intermittent shortages. Additionally demand has increased from average of 51 packs per month to 105 packs per month. |
Health Canada comments |